ENANTA PHARMACEUTICALS INC Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENANTA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ENANTA PHARMACEUTICALS INC for February 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 28 2020 | ENTA | ENANTA PHARMACEUTI ... | Vance Terry | Director | Option Exercise | A | 51.04 | 10,000 | 510,400 | 10,000 | |
Feb 28 2020 | ENTA | ENANTA PHARMACEUTI ... | Russell Lesley | Director | Option Exercise | A | 51.04 | 10,000 | 510,400 | 10,000 | |
Feb 28 2020 | ENTA | ENANTA PHARMACEUTI ... | Peterson Kristine | Director | Option Exercise | A | 51.04 | 10,000 | 510,400 | 10,000 | |
Feb 28 2020 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | A | 51.04 | 10,000 | 510,400 | 10,000 | |
Feb 28 2020 | ENTA | ENANTA PHARMACEUTI ... | CARTER BRUCE L A | Director | Option Exercise | A | 51.04 | 10,000 | 510,400 | 10,000 | |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Payment of Exercise | F | 52.76 | 3,122 | 164,717 | 649,689 | 652.8 K to 649.7 K (-0.48 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 8,910 | 0 | 652,811 | 643.9 K to 652.8 K (+1.38 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 1,485 | 0 | 643,901 | 642.4 K to 643.9 K (+0.23 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Payment of Exercise | F | 52.76 | 3,122 | 164,717 | 649,689 | 652.8 K to 649.7 K (-0.48 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 8,910 | 0 | 652,811 | 643.9 K to 652.8 K (+1.38 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 1,485 | 0 | 643,901 | 642.4 K to 643.9 K (+0.23 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Payment of Exercise | F | 52.76 | 940 | 49,594 | 24,605 | 25.5 K to 24.6 K (-3.68 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Grant | A | 0.00 | 2,475 | 0 | 25,545 | 23.1 K to 25.5 K (+10.73 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Grant | A | 0.00 | 412 | 0 | 23,070 | 22.7 K to 23.1 K (+1.82 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Payment of Exercise | F | 52.76 | 1,091 | 57,561 | 15,634 | 16.7 K to 15.6 K (-6.52 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 2,925 | 0 | 16,725 | 13.8 K to 16.7 K (+21.20 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 487 | 0 | 13,800 | 13.3 K to 13.8 K (+3.66 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Payment of Exercise | F | 52.76 | 1,089 | 57,456 | 305,915 | 307 K to 305.9 K (-0.35 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Grant | A | 0.00 | 2,925 | 0 | 307,004 | 304.1 K to 307 K (+0.96 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Grant | A | 0.00 | 487 | 0 | 304,079 | 303.6 K to 304.1 K (+0.16 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Payment of Exercise | F | 52.76 | 545 | 28,754 | 41,084 | 41.6 K to 41.1 K (-1.31 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Grant | A | 0.00 | 1,350 | 0 | 41,629 | 40.3 K to 41.6 K (+3.35 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Grant | A | 0.00 | 225 | 0 | 40,279 | 40.1 K to 40.3 K (+0.56 %) |